Real-world experience and outcomes of decitabine/cedazuridine or azacitidine for the treatment of myelodysplastic syndrome/chronic myelomonocytic leukemia.
Saved in:
| Title: | Real-world experience and outcomes of decitabine/cedazuridine or azacitidine for the treatment of myelodysplastic syndrome/chronic myelomonocytic leukemia. |
|---|---|
| Authors: | Salter, Brittany1 (AUTHOR) brittany.salter@medportal.ca, Ge, Sarah2 (AUTHOR), Garcia-Horton, Alejandro1 (AUTHOR), Berg, Tobias1 (AUTHOR), Leber, Brian1 (AUTHOR), Walker, Irwin1 (AUTHOR), Dalmia, Shreyash1 (AUTHOR), Radford, Michael1 (AUTHOR), Lepic, Kylie1 (AUTHOR), Khalaf, Dina3 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Jan2026, Vol. 67 Issue 2, p460-467. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10428194 |
|---|---|
| DOI: | 10.1080/10428194.2025.2577861 |
